We describe what we believe is only the second reported case ofprimitive neuroectodermal tumor ofthe mandible. Our patient was successfully treated initially with surgery and adjuvant radiation and chemotherapy, but 18 months later she developed a fatal pulmonary metastasis. Although this tumor is aggressive and prone to recurrence and metastasis, early intervention might improve the prognosis in affectedpatients. Inpatients with unresectable disease , radiation and chemotherapy might have palliative value.
An x-ray revealed that the right mandible had a "motheaten" appearance that extended from the subcondylar area on the right to the symphyseal area on the left; obliteration of the right inferior alveolar canal was also evident (figure 1). Computed tomography (CT) demonstrated significant bone loss in the right mandible (figure 2).
A presumptive diagnosis of osteomyelitis was made, and the patient was taken to the operating room for debridement or resection of the involved bone. Intraoperatively, however , the surgeon discovered a mass that involved the masseter and the lateral pterygoid muscles ; the surgeon also noted that the bone had an eroded appearance. Analysis of an intraoperatively obtained frozen section revealed that the mass was a poorly differentiated carcinoma. A segmental resection of the mandible was performed, and the mandible was stabilized with a titanium hollow-screw osseointegrating reconstruction plate. The final pathology findings were consistent with a PNET (figure 3), and the patient was referred to an otolaryngologist (lM.B .).
Magnetic resonance imaging of the head and neck demonstrated obliteration of the tissue planes that separate the masseter muscle and the medial and lateral pterygoid muscles. The presence of artifact from the mandibular reconstruction plate made it difficult to assess the cranial extent of muscle involvement,·but the floor of the middle cranial fossa appeared to be intact. No adenopathy was noted. CT of the chest did not detect any definitive evidence of metastatic disease.
The otolaryngology service performed a tracheostomy and en bloc resection of the right infratemporal fossa, the facial nerve, and the mandible from the right condyle to the left parasymphysis (figure 4). Selective neck dissection at levels I, II, and III was also performed. Subsequently, a plastic and reconstructive surgeon (MJ.S .) created a free osteocutaneous fibula flap to reconstruct the mandible and grafted the great auricular nerve to the facial nerve branches ( figure 5 ).
Postoperatively, the patient underwent chemotherapy with six cycles of etoposide (VP-16) and ifosfamide . Palliative external-beam irradiation was directed to the Figure 1 . Preope ratively, a panoramic x-ray of the mandib le shows that the bone has a "moth-eaten " appearance f rom the right subcondylar area to the symphysis , Obliteration of the right inf erior alveolar canal is also evident.
L5 and S 1 vertebral bodies. Wh en the patient continued to compl ain of back pain , she underwent a bone scan , which detected an abnormal uptake in the left hip and in the T6 and Ll -2 spine, suggesting skeletal metastases. A con sultation with a radi ation oncolo gist was obtained.
Frozen-section analyses of a lymph node specimen and a perim andibular soft-tiss ue spec imen confirmed that the tum or was a poorly differenti ated carcin om a. Immunohistochemi cal tests were positive for neuron -speci fic enolase, immunoreactive neurofil ament s, CD57 (Leu-7), and synaptophys in. Con versely, tests were negat ive for AEl/ AE3 monoclon al antibody, desmin, CD99 (MIC), chromogranin, CAM 5.2, S-IOOprotein, glial fibrillary acidic protein, immunoreacti ve calcitonin, immunoreactive parathyroid hormone, and epithelial membrane antigen.
Electron microscopy of the tumor identified clusters of three or four small, round to slightl y elongated cells that were separated by coll agen-rich connective tissue . The individual tumor cells pos sessed several primitive cell junctions. Basal lamina material was not noted. The nuclei were round and many were indented, and they featured both prominent nucl eoli and small amounts of peripherally located heterochromatin . Th e cytoplasm was mod erately scant and contained a normal complement of orga nelles. Neurosecr etory granules and microtubules, however, were not observed. Ma ny of the tumo r cells had perinuclear bundles of intermedi ate filaments. Glycogen particl es were observed infrequent ly. These electron microsc opic findin gs were also consis tent with a PNET.
At the l-year follow-up, the patient had no evidence of local or regional rec urre nce. However, 6 months later she developed pulmonary metastatic disease and died; at the time of her death , she had not had a local or regional recurrence.
Discussion
PNETs were init ially describ ed by Stout in 1918. 8 retrop eritoneum , extremities, bone, and paraspin al sites.' Today, this tumor is believed to be a neoplasm of nonneural soft tissue that primarily affec ts children and adolescents."
The actual incid ence of PNET is difficult to ascertain because diagnostic criteria have only rece ntly been delineated .' :" These tum ors ca n occ ur in any age group, but most occ ur in adolescents. Th ere is no appare nt pred ilection for either sex . Th ese tum ors are most ofte n found (in decreasing order of frequency) in the ches t, pelvi s, abdomen, and extremities.v-' Most reports have show n that the lowest incidence is in the head and neck region. P ? " In such cases, PNETs ha ve usually been repo rted in the craniofac ial skeleton area, including the temporal area,' skull," orbit,14,15masseter muscle," and maxilla,17 To the best of our knowledge, only one other repo rt of a PNET of the mandibl e has been publi shed .' Among the cell line s that might be responsible for the development ofPNETs, there are three likely candidates: the neural crest, primordial ger m cells, and uncommitted mesenchym al cells. The initial enthusias m for the neural crest as the origin has waned, and it is now believed that the likely progenitors of PNETs are mesench ymal stem cells."
ENT
The exact classification of these rare neopl asms has been a source of continued controversy.v'<":" Dehner reviewed the contemp orary medical literature and discovered a distinction between a centra l PNET and a peripheral PNET. 18 PNETs are typically gro uped with other round, smallcell tumors, including Ewin g ' s sarcoma, neuroblastoma, lymph oma, and rhabdomyosarcoma. Light micr oscopi c exa mination gene rally reve als that PNETs contain shee ts of small, round to oval cells with a scant amount of cytoplasm and coa rse chromatin material. The presence of a rosette formation is generally believed to be necessary in order to make the diagnosis. 5 ,9.20.22,23 The presenc e of a cytoplasmic process, along with fila ments, microtubules, and neu rosecretory granules, can be seen on electron microscopy.v -" Immu nohistochemical studies have impro ved the pathologi st's ability to differentiate these small-cell tum ors, PNETs are generally positi ve for neuron-specific enolase , neurofilament, HNK-I (Leu-7), S-IOO protein, and MB 2. 5 , 9, 23, 24Molecular assays are also being used to diagno se Ewing's sarcoma and PNET, and the polym era se chain reaction can be used to identi fy the Volume 82, Number 3 Figure 4 , Photograph shows the resected specimen obtained during the second surgery. The mandibular reconstruction plate had been placed during the previous surgery, common chromosomal translocations found in variou s tumors. 13 No large radiographic series of patients with PNET has been publi shed . In a small series of eight patients with Askin ' s tumors of the chest wall, Sabate et al found a softtissue mass in all patients, but only two demon strated bony erosi on." Radi onuclide examination with technetium 99m detected bone invol vement in six of these patients. CT showed intratumor calc ification in two patient s, and the tumo r enhanced with intravenou s contrast in all eight. Sabate et al concluded that the radiolo gic featur es of Askin ' s tumors are not pathognomonic and that these tumors cannot be diagno sed solely on the basis of radiographic techniques.
Peripheral PNETs are highly aggressive and have a propensity for local recurrence and met astasis to the lung, bone, and bone marrow .v' After a tiss ue diagnosis has been made, the patient shou ld undergo a full metastatic work-up, including a chest x-ray, CT of the lungs , a bone scan, and bone marrow aspiration to ascertain whether the tumor has metastasized. Bone ero sion has been reported to be a common initial finding . " Simil arly , many affected patients have metast atic disease; rates of metast asis in three large series ranged from 20 to 31%.1,3,4 The prognosis for patients with peripheral PNET is poor. Jone s and McGill reported that only 65% of patients they studied were still alive 2 years after diagno sis.' In patients who had metastatic disease, only 38% were alive at 2 years.'
In an interesting report , Cohn describ ed a patient who had a mass in the arm and periph eral neuropathy of the median nerve ." Cohn noted the presence of von Recklingh ausen ' s disease and an epithelial neopla sm of the median nerv e. The patient underw ent an initial resection and a subsequent resection for a recurrent lesion. Ultim ately, the arm was amput ated at the junction of the middl e and distal third s. There was no subsequent evidence of recurrence or metastasis.
Even though PNET is highly aggressive , it has been shown to be curable with multimodal therapy in some cases . In a large series, Kushner et al found that outcomes were more favorable among patients who underwent early surgical removal combined with radiation and doseintensive chemotherapy.' The recommended manner of treatment is similar to that for Ewin g' s sarcoma.v-" Surgical treatment of this lesion in the head and neck can be difficul t in light of anatomic considerations." Frequently used chemotherapeutic agents include cyclophosphamide, ifosfamide, vincristine, doxorubi cin, and actinomycin D. Radiation is generally admini stered as an adjuvant therapy when surgic al excision is incomplete, but it can also be used as a primary treatment for unresected lesions. Although PNETs are believed to be radiosensitive, radiation is not believed to be adequate to cure macroscopic diseas e.I Radiation therapy is usually given to doses of 55 to 60 Gy. In conclu sion, PNET is an aggressive tumor that is rarely encountered in the head and neck. It is characterized by rapid growth , cranial neuropathy, and manifestations of bone erosion. Involvement of the craniofacial skeleton can mimi c osteomyelitis and cause a delay in diagnosis and treatment. Diagnosis depends on extensive histologic evaluation, includin g immunohistochemistry and electron micro scopy . Treatment should include aggressive surgical resection combined with adjuvant radiation and chemotherapy. Because the rate of distant metastasis at the initial diagnosi s approaches 30%, preoperative evaluation of the chest, bone , and bone marrow is warranted.P " Radi ation and chemotherapy have palliative value in unresectable cases. Heightened awareness and early intervention might result in a better chance for a good outcome in patients with this aggressive tumor.
